Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Analysis-German budget row prises open debt brake debate
Post Content Post Views: 124
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. Post Views: 118
Fed Chair Powell calls talk of cutting rates ‘premature’ and says more hikes could happen
Federal Reserve Chairman Jerome Powell on Friday pushed back on market expectations for aggressive interest rate cuts ahead. Post Views: 121
Azuki DAO rebrands to ‘Bean’ as it drops lawsuit against founder
Post Content Post Views: 133
iRobot shares close up 39% on report Amazon deal set to get EU approval
Shares of iRobot, the maker of Roomba vacuums, closed up about 39% Friday after a report said the European Union is set to approve Amazon’s acquisition. Post Views: 114
Warning: SXYAY is at high risk of cutting its dividend
Post Content Post Views: 121